company background image
5069

J. B. Chemicals & PharmaceuticalsBSE:506943 Stock Report

Market Cap

₹139.1b

7D

0.8%

1Y

72.1%

Updated

17 Oct, 2021

Data

Company Financials +
506943 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance4/6
Financial Health6/6
Dividends4/6

506943 Overview

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally.

Price History & Performance

Summary of all time highs, changes and price drops for J. B. Chemicals & Pharmaceuticals
Historical stock prices
Current Share Price₹1,799.45
52 Week High₹892.60
52 Week Low₹1,984.75
Beta-0.20
1 Month Change3.47%
3 Month Change-5.33%
1 Year Change72.11%
3 Year Change491.83%
5 Year Change371.68%
Change since IPO35,252.66%

Recent News & Updates

Shareholder Returns

506943IN PharmaceuticalsIN Market
7D0.8%0.6%2.3%
1Y72.1%23.5%68.3%

Return vs Industry: 506943 exceeded the Indian Pharmaceuticals industry which returned 23.5% over the past year.

Return vs Market: 506943 exceeded the Indian Market which returned 68.3% over the past year.

Price Volatility

Is 506943's price volatile compared to industry and market?
506943 volatility
506943 Beta-0.20
Industry Beta0.60
Market Beta1

Stable Share Price: 506943 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: 506943's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19764,122Nikhil Choprahttps://www.jbcpl.com

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. The company manufactures a range of specialty products that include various pharmaceutical dosage forms. Its principal products include Cilnidipine, Ranitidine, and Metronidazole.

J. B. Chemicals & Pharmaceuticals Fundamentals Summary

How do J. B. Chemicals & Pharmaceuticals's earnings and revenue compare to its market cap?
506943 fundamental statistics
Market Cap₹139.07b
Earnings (TTM)₹4.47b
Revenue (TTM)₹21.26b

31.1x

P/E Ratio

6.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
506943 income statement (TTM)
Revenue₹21.26b
Cost of Revenue₹7.53b
Gross Profit₹13.73b
Expenses₹9.26b
Earnings₹4.47b

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)57.89
Gross Margin64.58%
Net Profit Margin21.04%
Debt/Equity Ratio2.5%

How did 506943 perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

28%

Payout Ratio

Valuation

Is J. B. Chemicals & Pharmaceuticals undervalued compared to its fair value and its price relative to the market?

31.08x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 506943 (₹1799.45) is trading above our estimate of fair value (₹1504.93)

Significantly Below Fair Value: 506943 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 506943 is poor value based on its PE Ratio (31.1x) compared to the Indian Pharmaceuticals industry average (26x).

PE vs Market: 506943 is poor value based on its PE Ratio (31.1x) compared to the Indian market (22.2x).


Price to Earnings Growth Ratio

PEG Ratio: 506943 is poor value based on its PEG Ratio (1.8x)


Price to Book Ratio

PB vs Industry: 506943 is overvalued based on its PB Ratio (7.7x) compared to the IN Pharmaceuticals industry average (3.2x).


Future Growth

How is J. B. Chemicals & Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

17.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 506943's forecast earnings growth (17.3% per year) is above the savings rate (6.7%).

Earnings vs Market: 506943's earnings (17.3% per year) are forecast to grow slower than the Indian market (19.2% per year).

High Growth Earnings: 506943's earnings are forecast to grow, but not significantly.

Revenue vs Market: 506943's revenue (14.3% per year) is forecast to grow faster than the Indian market (12.9% per year).

High Growth Revenue: 506943's revenue (14.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 506943's Return on Equity is forecast to be high in 3 years time (23.3%)


Past Performance

How has J. B. Chemicals & Pharmaceuticals performed over the past 5 years?

25.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 506943 has a large one-off gain of ₹1.0B impacting its June 30 2021 financial results.

Growing Profit Margin: 506943's current net profit margins (21%) are higher than last year (17.8%).


Past Earnings Growth Analysis

Earnings Trend: 506943's earnings have grown significantly by 25.3% per year over the past 5 years.

Accelerating Growth: 506943's earnings growth over the past year (35.8%) exceeds its 5-year average (25.3% per year).

Earnings vs Industry: 506943 earnings growth over the past year (35.8%) underperformed the Pharmaceuticals industry 35.8%.


Return on Equity

High ROE: 506943's Return on Equity (24.7%) is considered high.


Financial Health

How is J. B. Chemicals & Pharmaceuticals's financial position?


Financial Position Analysis

Short Term Liabilities: 506943's short term assets (₹15.5B) exceed its short term liabilities (₹3.5B).

Long Term Liabilities: 506943's short term assets (₹15.5B) exceed its long term liabilities (₹794.1M).


Debt to Equity History and Analysis

Debt Level: 506943's debt to equity ratio (2.5%) is considered satisfactory.

Reducing Debt: 506943's debt to equity ratio has reduced from 12.8% to 2.5% over the past 5 years.

Debt Coverage: 506943's debt is well covered by operating cash flow (699.7%).

Interest Coverage: 506943's interest payments on its debt are well covered by EBIT (229.3x coverage).


Balance Sheet


Dividend

What is J. B. Chemicals & Pharmaceuticals's current dividend yield, its reliability and sustainability?

0.92%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 506943's dividend (0.92%) is higher than the bottom 25% of dividend payers in the Indian market (0.33%).

High Dividend: 506943's dividend (0.92%) is low compared to the top 25% of dividend payers in the Indian market (1.35%).


Stability and Growth of Payments

Stable Dividend: 506943's dividend payments have been volatile in the past 10 years.

Growing Dividend: 506943's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (28.5%), 506943's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: 506943's dividends in 3 years are forecast to be well covered by earnings (20.8% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.2yrs

Average board tenure


CEO

Nikhil Chopra

0.83

Tenure

₹31,873,164

Compensation

Mr. Nikhil Ashokkumar Chopra serves as Chief Executive Officer and Whole-Time Director at J. B. Chemicals & Pharmaceuticals Limited since December 23, 2020 and has been its Director since May 10, 2020. He...


CEO Compensation Analysis

Compensation vs Market: Nikhil's total compensation ($USD424.96K) is about average for companies of similar size in the Indian market ($USD421.99K).

Compensation vs Earnings: Insufficient data to compare Nikhil's compensation with company performance.


Board Members

Experienced Board: 506943's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: 506943 insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

J. B. Chemicals & Pharmaceuticals Limited's employee growth, exchange listings and data sources


Key Information

  • Name: J. B. Chemicals & Pharmaceuticals Limited
  • Ticker: 506943
  • Exchange: BSE
  • Founded: 1976
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: ₹139.065b
  • Shares outstanding: 77.28m
  • Website: https://www.jbcpl.com

Number of Employees


Location

  • J. B. Chemicals & Pharmaceuticals Limited
  • Cnergy IT Park
  • Unit A2, 3rd floor & Unit A, 8th floor
  • Mumbai
  • Maharashtra
  • 400025
  • India

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/17 12:03
End of Day Share Price2021/10/14 00:00
Earnings2021/06/30
Annual Earnings2021/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.